Bolon Jeffrey, Samson Amy, Irwin Natalie, Murray Lyle, Mbodi Langanani, Stacey Sarah, Aikman Nicholas, Moonsamy Louell, Zamparini Jarrod
Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Division of Medical Oncology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
South Afr J HIV Med. 2023 May 26;24(1):1490. doi: 10.4102/sajhivmed.v24i1.1490. eCollection 2023.
Cervical cancer is the most common malignancy affecting South African women aged 15-44 years, with a higher prevalence among women living with HIV (WLWH). Despite recommendations for a screening target of 70%, the reported rate of cervical cancer screening in South Africa is 19.3%.
To investigate the adherence of healthcare workers to cervical cancer screening guidelines in a tertiary-level HIV clinic.
A retrospective cross-sectional record audit of women attending the Charlotte Maxeke Johannesburg Academic Hospital HIV Clinic over a 1-month period.
Out of 403 WLWH who attended the clinic, 180 (44.7%) were screened for cervical cancer in the 3 years prior to the index consultation. Only 115 (51.6%) of those women with no record of prior screening were subsequently referred for screening. Women who had undergone screening in the previous 3 years were significantly older (47 years vs 44 years, = 0.046) and had a longer time since diagnosis of their HIV (12 years vs 10 years, = 0.001) compared to women who had not undergone screening. There was no significant difference in CD4 count or viral suppression between women who had and had not undergone screening.
The rate of cervical cancer screening in our institution is below that recommended by the World Health Organization and the South African National Department of Health.
宫颈癌是影响南非15 - 44岁女性的最常见恶性肿瘤，在感染艾滋病毒的女性（WLWH）中患病率更高。尽管建议筛查目标为70%，但南非报告的宫颈癌筛查率为19.3%。
调查三级艾滋病毒诊所医护人员对宫颈癌筛查指南的遵守情况。
对在夏洛特·马克西克约翰内斯堡学术医院艾滋病毒诊所就诊1个月的女性进行回顾性横断面记录审核。
在403名就诊的WLWH中，180名（44.7%）在索引咨询前3年接受了宫颈癌筛查。在那些没有既往筛查记录的女性中，只有115名（51.6%）随后被转诊进行筛查。与未接受筛查的女性相比，在过去3年接受过筛查的女性年龄显著更大（47岁对44岁，P = 0.046），自诊断艾滋病毒以来的时间更长（12年对10年，P = 0.001）。接受筛查和未接受筛查的女性之间的CD4细胞计数或病毒抑制情况没有显著差异。
我们机构的宫颈癌筛查率低于世界卫生组织和南非国家卫生部建议的水平。
